EarningsQ4 2025 Earnings Report

Novo Nordisk (NVON) Q4 2025 Earnings Report

1 Followers

MX:NVON Q4 2025 EPS Results

Actual EPS$17.53

Consensus EPS$16.96

Beat/MissBeat by +$0.57

One Year Ago EPS$16.28

Actual Revenue$226.63B

Expected Revenue$222.84B

Beat/MissBeat by +$3.80B

YoY Revenue Growth+0.66%

QuarterQ4 2025

Date02/04/2026

TimeDuring Market Hours

Conference CallWednesday, February 4, 2026

MX:NVON Upcoming Earnings

Novo Nordisk's next earnings date is estimated for November 4, 2026, based on past reporting schedules.

MX:NVON Q4 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 04, 2026	2026 (Q3)	13.63 / -	12.715	―
Aug 04, 2026	2026 (Q2)	14.15 / 17.55	17.07	2.80% (+0.48)
May 06, 2026	2026 (Q1)	16.24 / 19.16	18.282	4.82% (+0.88)
Feb 04, 2026	2025 (Q4)	16.96 / 17.53	16.28	7.67% (+1.25)
Nov 05, 2025	2025 (Q3)	14.04 / 12.71	16.188	-21.45% (-3.47)
Aug 06, 2025	2025 (Q2)	16.89 / 17.07	12.09	41.19% (+4.98)
May 07, 2025	2025 (Q1)	16.81 / 18.28	14.957	22.24% (+3.33)
Feb 05, 2025	2024 (Q4)	15.27 / 16.28	13.156	23.74% (+3.12)
Nov 06, 2024	2024 (Q3)	16.17 / 16.19	13.064	23.91% (+3.12)
Aug 07, 2024	2024 (Q2)	13.01 / 12.09	11.723	3.13% (+0.37)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed